FIR against five people filed by Maharashtra FDA for blackmarketing of remedisivir and tocilizumab

The Maharashtra Food and Drug Administration (FDA), along with Anti Extortion Cell (AEC), has filed the FIR for black marketing racket of remdisivir and tocilizumab drugs. The team also seized other therapeutic medicines worth Rs 3,13,482.

Viraj Paunikar, Joint Commissioner, Thane FDA, informed, “Two days back, an activist informed the Thane, Mumbai police about the black marketing of COVID-19 drugs within the vicinity. Based on the information, we put up a trap and arrested five people involved in selling Cipla’s cipremi (remdesivir) and actemra (tocilizumab) without a drug sale license; and we caught them red-handed selling remdesivir at Rs 25,000 (the company’s MRP of the said drug is Rs 4,000) and tocilizumab approximately at Rs 80,000, which are much higher than the market retail prices. All five of them are found guilty in violating different sections of the Indian Penal Code (IPC) like section 420, 34, etc., along with DPCO, essential commodities Act, Drugs and Cosmetic Rules/Act, etc. Hence, the local police have filed the first information report (FIR) against them,” informed Paunikar.

“From the initial investigation, the team realised that the master mind of this racket was Amitabh Das, a resident of Kalamboli, Raigad district. From his house, we have collected other medicines like anti-cancer drug, MTP kits, etc; and the team is investigating about the source of these medicines.” He further added
Jugalkishor B Mantri, Joint Commissioner, State Controller, Maharashtra and State Drug Controlling Authority of Mumbai, said that, “Together, local police administration and state FDA officers are working aggressively to bring down the unethical marketing practices in the state.”

“To address the issues related to the unavailability as well as black marketing of essential drugs in the state, we have recently launched the 24×7 control room at our Mumbai head office, and infact, we have got a lead of another black marketing of these medicines (remdesivir and tocilizumab) and we are working on that lead and hopefully in few days will be able to spot that racket too.” He further added.

  • Related Posts

    Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

    Patients for Patient Safety Foundation (PFPSF) Partners with CAHO to RollOut an Excellence Program New Delhi: Thanks to some well-meaning organizations, patients are going to be lord of all they…

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Inquiry reveals ‘fake credentials, illegal diagnostic centres’ in Pilibhit; report sent to DM

    Inquiry reveals ‘fake credentials, illegal diagnostic centres’ in Pilibhit; report sent to DM

    Medical devices PLI scheme drives local output of MRI, CT scanners, heart valves: Centre

    Medical devices PLI scheme drives local output of MRI, CT scanners, heart valves: Centre

    MPSC Drug Inspector paper leak: 4 more arrested, total arrests rise to 11

    MPSC Drug Inspector paper leak: 4 more arrested, total arrests rise to 11

    Arogya Manthan 2026 to launch new digital health and health assurance initiatives

    Arogya Manthan 2026 to launch new digital health and health assurance initiatives

    Bengaluru drug scam: Rs 12cr spurious Pfizer stock sold to hospitals since Feb 2025; kingpin among 8 held

    Bengaluru drug scam: Rs 12cr spurious Pfizer stock sold to hospitals since Feb 2025; kingpin among 8 held

    Banned in India, sold in Maharashtra: Man held over fake Pakistani beauty cream

    Banned in India, sold in Maharashtra: Man held over fake Pakistani beauty cream